Keyphrases
Patient Management
100%
Diagnostic Value
100%
Positron Emission Tomography-computed Tomography (PET-CT)
100%
Impact on Patients
100%
18F-fluorodeoxyglucose (18F-FDG)
100%
Diagnostic Impact
100%
Lung Cancer Recurrence
100%
Clinical Management
18%
Non-small Cell Lung Cancer (NSCLC)
18%
CT Studies
18%
CT Data
18%
Therapeutic Approaches
9%
Treatment Options
9%
Tissue Sampling
9%
Histologic
9%
Accurate Localization
9%
No Evidence of Disease
9%
Diagnosis Management
9%
Clinical Treatment
9%
Positive Predictive Value
9%
Radiologic
9%
Negative Predictive Value
9%
Final Diagnosis
9%
Sensitivity Specificity
9%
Diagnostic Performance
9%
Treatment Planning
9%
Recurrent Disease
9%
Radiological Findings
9%
Diagnostic Procedures
9%
Management Plan
9%
Hybrid Imaging
9%
Biochemical Detection
9%
Anatomic Localization
9%
Suspicious Lesions
9%
FDG Uptake
9%
Lesion Classification
9%
Recurrent Lung Cancer
9%
Option 4
9%
Medicine and Dentistry
Diagnosis
100%
Patient Care
100%
Lung Cancer
100%
Cancer Recurrence
100%
Positron Emission Tomography-Computed Tomography
100%
Fluorodeoxyglucose F 18
100%
Recurrent Disease
45%
Positron Emission Tomography
36%
Clinical Management
18%
Non Small Cell Lung Cancer
18%
Disease
9%
Biopsy
9%
Sensitivity and Specificity
9%
Diagnostic Procedure
9%
Final Diagnosis
9%
Diagnostic Performance
9%
Treatment Planning
9%
Tissue Sampling
9%
Hybrid Imaging
9%